Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mehraban Pouladi"'
Autor:
Saloumeh Gholami, Mehraban Pouladi
Publikováno v:
Iranian Studies. 52:3-59
About 150 years ago, after Avestan researchers such as Jackson, Browne, and Westergaard had unsuccessfully attempted to discover new manuscripts in Iran, it was assumed that there were few or no Avestan manuscripts remaining in Iran. However, recent
Autor:
Amir Reza Jalilian, Ali Khalaj, Behrouz Alirezapoor, Mehraban Pouladi, Yousef Fazaeli, Davoud Beiki, Stephan Maus, Ayuob Aghanejad
Publikováno v:
Scientia Pharmaceutica
Volume 82
Issue 1
Pages 29-42
Volume 82
Issue 1
Pages 29-42
In order to develop a possible C-X-C chemokine receptor type 4 (CXCR4) imaging agent for oncological scintigraphy, [67Ga]-labeled 1,1′-[1,4-Phenylene-bis(methylene)]bis(1,4,8,11-tetraazacyclotetradecane) ([67Ga]-AMD3100) was prepared by using [67Ga
Autor:
Hossein Afarideh, Samaneh Zolghadri, Mehraban Pouladi, Mohammad Ghannadi-Maragheh, Hassan Yousefnia, Ali Bahrami-Samani, Yousef Fazaeli, Amir Reza Jalilian
Publikováno v:
ract. 101:445-452
In this study, the 166Ho-triethylene tetramine hexa (methylene phosphonic acid) (166Ho-TTHMP) complex was prepared as a bone palliation agent. The complex was successfully prepared using an in-house synthesized TTHMP ligand and [166Ho]HoCl3. Ho-166 c
Autor:
Davoud Beiki, Stephan Maus, Ali Khalaj, Amir Reza Jalilian, Ayoub Aghanejad, Yousef Fazaeli, Behrouz Alirezapoor, Mehraban Pouladi
Publikováno v:
Nuclear Medicine and Biology. 41:640-641
Autor:
Behrouz Alirezapour, Mehraban Pouladi, Sedigheh Moradkhani, Gholamreza Aslani, Amir Reza Jalilian, M. Mirzaii, Saeed Rajabifar
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 10, Iss 1, Pp 112-120 (2014)
Context: Herceptin and its fragments have been radiolabeled and used in the imaging of human epidermal growth factor receptor 2 (HER2)/neu-positive tumors and development of diagnostic kits is of great importance in radiopharmacy. Aims: In this study